BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 0.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,633 shares of the medical research company’s stock after […]